Long-Term Effect of a Chicken-Based Diet Versus Enalapril on Albuminuria in Type 2 Diabetic Patients With Microalbuminuria

Journal of Renal Nutrition

Volumn 18, Issue 5, 2008, Pages 440-447

  de Mello, Vanessa D F ^a   Zelmanovitz, Themis ^a   Azevedo, Mirela J ^a   de Paula, Tatiana P ^a   Gross, Jorge L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LIPID;

ALBUMINURIA; ANIMAL; ARTICLE; BLOOD; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET THERAPY; DRUG EFFECT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEAT; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; CHICKENS; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIET; DIETARY PROTEINS; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; LIPIDS; MALE; MEAT; MIDDLE AGED; NUTRITION ASSESSMENT; TREATMENT OUTCOME;

EID: 49449101254     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.04.010     Document Type: Article

References (25)

1. Adler A.I., Stevens R.J., Manley S.E., et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63 (2003) 225-232
2. American Diabetes Association: Standards of medical care in diabetes-2007. Position statement. Diabetes Care 30 Suppl 1 (2007) S4-S41
3. Gross J.L., Azevedo M.J., Silveiro S.P., et al. Diabetic nephropathy: diagnosis, prevention and treatment. Diabetes Care 28 (2005) 164-176
4. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO-HOPE Substudy. Lancet 355 (2000) 253-259
5. Parving H.H., Lehnert H., Bröchner-Mortensen J., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 (2001) 870-878
6. Chan J.C., Ko G.T., Leung D.H., et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney Int 57 (2000) 590-600
7. Walker J.D., Bending J.J., Dodds R.A., et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 2 (1989) 1411-1415
8. Hansen H.P., Christensen P.K., Tauber-Lassen E., et al. Low protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int 55 (1999) 621-628
9. Pijls L.T.J., de Vries H., van Eijk J.T.M., et al. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr 56 (2002) 1200-1207
10. Gross J.L., Zelmanovitz T., Moulin C.C., et al. Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial. Diabetes Care 25 (2002) 645-651
11. de Mello V.D., Zelmanovitz T., Perassolo M.S., et al. Withdrawal of red meat from the usual diet reduces albuminuria and improves the lipid profile in type 2 diabetic patients with macroalbuminuria. Am J Clin Nutr 83 (2006) 1032-1038
12. Franz M.J., Bantle J.P., Beebe C.A., et al. American Diabetes Association: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (technical review). Diabetes Care 25 (2002) 148-198
13. Maroni B.J., Steinman T.I., and Mitch W.E. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27 (1985) 58-65
14. Ravid M., Lang R., Rachmani R., et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 156 (1996) 286-289
15. U.S. Department of Agriculture, Agricultural Research Service: USDA national nutrient database for standard reference, release 15. 2002. Nutrient Data Laboratory home page, http://www.nal.usda.gov/fnic/foodcomp
16. Moulin C.C., Tiskievicz F., Zelmanovitz, et al. Use of weighed diet records in the evaluation of diets with different protein contents in patients with type 2 diabetes. Am J Clin Nutr 67 (1998) 853-857
17. Franz M.J., and Wheeler M.L. Nutrition therapy for diabetic nephropathy. Curr Diab Rep 3 (2003) 412-417
18. Keogh J.B., Grieger M.N., and Clifton P.M. Flow-mediated dilatation is impaired by a high saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 25 (2005) 1274-1279
19. Brown A.A., and Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 73 (2001) 673-686
20. Fried L.F., Orchard T.J., and Kasiske B.L. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59 (2001) 260-269
21. Mogensen C.E., Viberti G., Halimi S., et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 41 (2003) 1063-1071
22. Sengul A.M., Altuntas Y., Kurklu A., et al. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract 71 (2006) 210-219
23. Zatz R., Dunn B.R., Meyer T.W., et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77 (1986) 1925-1930
24. Ahmad J., Shafique S., Abidi S.M., et al. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects. Diabetes Res Clin Pract 60 (2003) 131-138
25. Rudberg S., Osterby R., Bangstad H.J., et al. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 42 (1999) 589-595